ClinicalTrials.Veeva

Menu

Use of EtCO2 as a PaCO2 Predictor Under Non Invasive Ventilation (NIV) in Cases of Acute Hypercapnic Respiratory Failure

L

Lausanne University Hospital (CHUV)

Status

Completed

Conditions

Hypercapnic Respiratory Failure

Study type

Observational

Funder types

Other

Identifiers

NCT01489150
EtCO2-NIV

Details and patient eligibility

About

In patients treated by Non invasive ventilation (NIV) due to acute hypercapnic respiratory failure, the interest of using the End-tidal Co2 measurement device "Capnostream" to evaluate PaCo2 and PaCo2 variations over time will be evaluated. Measurements will be done under normal expiration and under prolonged active and passive expiration maneuvers.

Enrollment

11 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ICU patient equipped with arterial line
  • NIV requirement
  • Hypercapnia: PaCO2 > 45mmhg

Exclusion criteria

  • Severe hemodynamic instability
  • Severe psychiatric disorders
  • nasal lesions
  • denied consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems